Leponex 200 mg tablete

Name	Leponex 200 mg tablete
Marketing Authorisation Number	HR-H-267582554
Active Substance	klozapin
Composition	jedna tableta sadrži 200 mg klozapina
Pharmaceutical Form	Tableta
Manufacturer	Madaus GmbH, Troisdorf, Njemačka
Marketing Authorisation Holder	Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska
Marketing Authorisation Date	12.11.2024
MA Period of Validity	12.11.2029
Classification Number	UP/I-530-09/23-01/159
Registration Number	381-12-01/171-24-09
Prescription	Medicinal product subject to medical prescription
Type of prescription	ograničeni recept
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	N05AH02
Marketing status	nije stavljeno u promet
SmPC	download
PL	download
Public Assessment Report	download
Summary of risk management plan	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
20 tableta u blisteru, u kutiji	HR-H-267582554-01	nije stavljeno u promet	-
30 tableta u blisteru, u kutiji	HR-H-267582554-02	nije stavljeno u promet	-
40 tableta u blisteru, u kutiji	HR-H-267582554-03	nije stavljeno u promet	-
50 tableta u blisteru, u kutiji	HR-H-267582554-04	nije stavljeno u promet	-
100 tableta u blisteru, u kutiji	HR-H-267582554-05	nije stavljeno u promet	-
20 tableta u blisteru s jediničnom dozom, u kutiji	HR-H-267582554-06	nije stavljeno u promet	-
30 tableta u blisteru s jediničnom dozom, u kutiji	HR-H-267582554-07	nije stavljeno u promet	-
40 tableta u blisteru s jediničnom dozom, u kutiji	HR-H-267582554-08	nije stavljeno u promet	-
50 tableta u blisteru s jediničnom dozom, u kutiji	HR-H-267582554-09	nije stavljeno u promet	-
100 tableta u blisteru s jediničnom dozom, u kutiji	HR-H-267582554-10	nije stavljeno u promet	-

Medicinal Products